August 2024 Veozah Drug Label Change Adds Warnings About Liver Toxicity and Abnormal Liver Tests
(Posted by Tom Lamb at Drug Injury Watch)
On September 12, 2024, the FDA announced a warning about the rare occurrence of
Law Offices of Thomas J. Lamb, P.A.
Website:
https://www.drug-injury.com/
Law Offices of Thomas J. Lamb, P.A. Blogs
Blog Authors
Latest from Law Offices of Thomas J. Lamb, P.A.
Syfovre Injections Side Effects Legal Compensation Cases Being Filed for Patients
By Tom Lamb
Drug Company Apellis Failed to Warn About Retinal Vasculitis Until a November 2023 Label Change
(Posted by Tom Lamb at Drug Injury Watch)
We are handling Syfovre injections side effects legal compensation cases being filed for patients…
No Warnings About Blood Clots From Ozempic, Wegovy, and Rybelsus in Drug Labels
By Tom Lamb
Growing Number of Pulmonary Embolism and DVT Cases Involving Semaglutide Reported by Patients
(Posted by Tom Lamb at Drug Injury Watch)
Wegovy, Rybelsus, and Ozempic have been associated with an increased risk of blood clots that can…
Wegovy, Rybelsus, and Ozempic Eye Side Effects: Semaglutide Linked to NAION
By Tom Lamb
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), or “Eye Stroke”, Can Cause Vision Loss
(Posted by Tom Lamb at Drug Injury Watch)
Wegovy, Rybelsus, and Ozempic eye side effects are possible given the recent findings that the active…
Syfovre Safety-Benefit Assessment by Europe’s Drug Regulator Differs From FDA
By Tom Lamb
EMA’s CHMP Does Not Approve Syfovre for a Second Time, Citing “significant risk of adverse events”
(Posted by Tom Lamb at Drug Injury Watch)
There seems to be some disagreement about the Syfovre safety-benefit assessment when it…
Wegovy, Rybelsus, and Ozempic Blood Clots Cases Are Not Part of Federal Court MDL at This Time
By Tom Lamb
Semaglutide-related Side Effects Include Ischemic Stroke, Pulmonary Embolism, and Deep Vein Thrombosis
(Posted by Tom Lamb at Drug Injury Watch)
Wegovy, Rybelsus, and Ozempic are drugs with semaglutide as their active ingredient. Semaglutide is associated with a…
Syfovre Retinal Vaso-occlusive Vasculitis Case Report Involving 78-year Old Woman With Vision Loss
By Tom Lamb
She Went to the Local ER With Loss of Vision 11 Days After Receiving an Intravitreal Syfovre (Pegcetacoplan) Injection
(Posted by Tom Lamb at Drug Injury Watch)
In the March 2024 edition of the American Journal of…
Syfovre Eye Injury Cases: More Questions Than Answers One Year After First Reports
By Tom Lamb
Retinal Vasculitis After Syfovre Injections: Etiology is Still Unknown and Incidence Rate Remains Unclear
(Posted by Tom Lamb at Drug Injury Watch)
Syfovre (pegcetacoplan) was approved by the FDA in February 2023 as an eye injection to…
Syfovre Case Report: Occlusive Retinal Vasculitis Shortly After Patient’s First Syfovre Injection
By Tom Lamb
Pre-Existing Allergy Toward Polyethylene Glycol (PEG) is Most Recent Causation Theory Offered by Apellis
(Posted by Tom Lamb at Drug Injury Watch)
In late January 2024, a leading medical journal for ophthalmologists and retina specialists, the Journal…
"New" Blood Clots Side Effect of Semaglutide Weight Loss Drugs Like Ozempic: Deep Vein Thrombosis
By Tom Lamb
Research Finding: Semaglutide Increased the Risk of Deep Vein Thrombosis (DVT) by 266% in Patients with Type 2 Diabetes
(Posted by Tom Lamb at Drug Injury Watch)
Semaglutide-containing drugs that are being used for weight loss purposes…